A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial).
Condition: Liver Cirrhosis Interventions: Drug: Human albumin; Drug: Enoxaparin; Drug: Standard medical treatment Sponsor: European Foundation for Study of Chronic Liver Failure Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2023 Category: Research Source Type: clinical trials